About Vijay Pande
Form D filings for Genesis Therapeutics in 2023 list Vijay Pande as director.
Vijay Pande first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Vijay Pande in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Vijay Pande works with at each company, as listed on that company's latest Form D.
Genesis Therapeutics, Inc. · Form D, Aug 25, 2023
EF
Evan Feinberg
PRESIDENT and CEO, director
PP
Peptiboon Prasit
Executive officer and director
WM
William Mccarthy
Executive officer
LB
Leonard Bell
Director
KJ
Kris Jenner
Director
BS
Benjamin Sklaroff
Executive officer